Anodyne Nanotech, a clinical-stage biotech company, today announced promising preclinical results for its proprietary HeroPatch™ platform, demonstrating the ability to transdermally deliver ...
Here, the authors present a targeted delivery strategy via irreversible aggregation of drug carriers in response to mild external heating by constructing two types of polymeric micelles with a ...
Mucus presents a formidable barrier to nanoparticle drug-delivery systems, but adding a coating of polymer molecules helps them sneak through the net. Mucus, the amorphous, sticky substance that ...
16 天
AZoM on MSNAn Overview of Biomaterials: Advancements and ApplicationsThe different types of biomaterials and their classifications (inert, active and resorbable) are defined and key properties ...
LMU researchers have investigated how cationic polymers organize on a molecular level when transporting RNA drugs. Cationic ...
A Loughborough University project will use computer simulations and practical experiments to explore whether there’s a safer, ...
We are designing, synthesizing, characterizing and evaluating novel polymeric materials for a wide array of dental and biomedical applications. Some of these materials, such as dental restorations, ...
Amid the pursuit of cutting-edge cancer therapies, Michael Adeniyi has emerged as a pioneering researcher whose work is ...
Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, unveiled new pharmacokinetic ("PK") data from its Phase 2a Eosinophilic Esophagitis ("EoE") program.
当前正在显示可能无法访问的结果。
隐藏无法访问的结果